62 related articles for article (PubMed ID: 19330806)
1. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.
Ahmad A; Kong D; Sarkar SH; Wang Z; Banerjee S; Sarkar FH
J Cell Biochem; 2009 Jun; 107(3):516-27. PubMed ID: 19330806
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.
Chinnakannu K; Chen D; Li Y; Wang Z; Dou QP; Reddy GP; Sarkar FH
J Cell Physiol; 2009 Apr; 219(1):94-9. PubMed ID: 19062173
[TBL] [Abstract][Full Text] [Related]
3. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.
Alexander RA; Prager GW; Mihaly-Bison J; Uhrin P; Sunzenauer S; Binder BR; Schütz GJ; Freissmuth M; Breuss JM
Cardiovasc Res; 2012 Apr; 94(1):125-35. PubMed ID: 22287577
[TBL] [Abstract][Full Text] [Related]
4. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
Bin Hafeez B; Adhami VM; Asim M; Siddiqui IA; Bhat KM; Zhong W; Saleem M; Din M; Setaluri V; Mukhtar H
Clin Cancer Res; 2009 Jan; 15(2):452-9. PubMed ID: 19147749
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma.
Malla RR; Gopinath S; Gondi CS; Alapati K; Dinh DH; Gujrati M; Rao JS
Cancer Gene Ther; 2011 Jun; 18(6):419-34. PubMed ID: 21394106
[TBL] [Abstract][Full Text] [Related]
6. Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs.
Chang YC; Wu CZ; Cheng CW; Chen JS; Chang LC
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895906
[TBL] [Abstract][Full Text] [Related]
7. Nanoformulated 3'-diindolylmethane modulates apoptosis, migration, and angiogenesis in breast cancer cells.
Harakeh S; Akefe IO; Saber SH; Alamri T; Al-Raddadi R; Al-Jaouni S; Tashkandi H; Qari M; Moulay M; Aldahlawi A; Abd Elmageed ZY; Mousa S
Heliyon; 2024 Jan; 10(1):e23553. PubMed ID: 38187226
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Molecular regulation of tumor cells migration and metastatic growth.
Matter ML; Gkretsi V
Front Oncol; 2023; 13():1329053. PubMed ID: 38044990
[No Abstract] [Full Text] [Related]
9. A Comprehensive Review of Health-Benefiting Components in Rapeseed Oil.
Shen J; Liu Y; Wang X; Bai J; Lin L; Luo F; Zhong H
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839357
[TBL] [Abstract][Full Text] [Related]
10. 3,3'-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis.
Munakarmi S; Shrestha J; Shin HB; Lee GH; Jeong YJ
Cells; 2021 May; 10(5):. PubMed ID: 34066056
[TBL] [Abstract][Full Text] [Related]
11. Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3'-diindolylmethane in an enzalutamide-resistant prostate cancer cell line.
Tsao CW; Li JS; Lin YW; Wu ST; Cha TL; Liu CY
Sci Rep; 2021 Jan; 11(1):1239. PubMed ID: 33441906
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in natural dietary non-phenolic bioactives on cancers metastasis.
Yen GC; Tsai CM; Lu CC; Weng CJ
J Food Drug Anal; 2018 Jul; 26(3):940-964. PubMed ID: 29976413
[TBL] [Abstract][Full Text] [Related]
13. A novel peptide blocking cancer cell invasion by structure-based drug design.
Yamada Y; Kanayama S; Ito F; Kurita N; Kobayashi H
Biomed Rep; 2017 Sep; 7(3):221-225. PubMed ID: 28819560
[TBL] [Abstract][Full Text] [Related]
14. Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer.
Kim SM
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447608
[TBL] [Abstract][Full Text] [Related]
15. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Lee GA; Hwang KA; Choi KC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
[TBL] [Abstract][Full Text] [Related]
16. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
[TBL] [Abstract][Full Text] [Related]
17. Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.
Zhang WW; Feng Z; Narod SA
J Biomed Res; 2014 Sep; 28(5):339-48. PubMed ID: 25332705
[TBL] [Abstract][Full Text] [Related]
18. Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
Ashour AA; Gurbuz N; Alpay SN; Abdel-Aziz AA; Mansour AM; Huo L; Ozpolat B
J Cell Mol Med; 2014 Nov; 18(11):2235-51. PubMed ID: 25215932
[TBL] [Abstract][Full Text] [Related]
19. Natural compounds as anticancer agents: Experimental evidence.
Wang J; Jiang YF
World J Exp Med; 2012 Jun; 2(3):45-57. PubMed ID: 24520533
[TBL] [Abstract][Full Text] [Related]
20. Recent progress on nutraceutical research in prostate cancer.
Li Y; Ahmad A; Kong D; Bao B; Sarkar FH
Cancer Metastasis Rev; 2014 Sep; 33(2-3):629-40. PubMed ID: 24375392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
